Graphene, power storage device, and electric device
US-9218916-B2 · Dec 22, 2015 · US
US11247904B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11247904-B2 |
| Application number | US-201916598410-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 10, 2019 |
| Priority date | Mar 4, 2014 |
| Publication date | Feb 15, 2022 |
| Grant date | Feb 15, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are a scroll preparing method using a two-dimensional material and a scroll prepared thereby. The scroll preparing method comprises preparing a two-dimensional material. The two-dimensional material is scrolled by providing an amphiphilic substance having a hydrophilic portion and a hydrophobic portion on the two-dimensional material. As a result, a scroll composite including the amphiphilic substance disposed inside a scroll structure is formed.
Opening claim text (preview).
The invention claimed is: 1. A scroll composite, comprising: a two-dimensional material scroll with open ends, wherein the two-dimensional material scroll has a sheet of two-dimensional material which is rolled up to form the scroll, the rolled-up sheet has a first edge exposed inside the scroll and a second edge opposite to the first edge is exposed outside of the scroll; and an amphiphilic substance disposed inside the scroll where the first edge exposed, wherein the amphiphilic substance is a bile acid derivative represented by Formula 2 below, a bile acid salt, a hydrate of a bile acid salt, a bile acid ester, or a bacteriophage: where n is 0, 1 or 2, and R 4 to R 7 are each independently a group represented by Formula 3, where B 1 is one group selected from the group consisting of L 1 is a linker of —W 1 -, -Q 1 -, -Q 2 —W 2 —, —W 2 -Q 1 -W 3 —, or —W 4 -Q 2 -W 5 -Q 3 -Q 6 -, W 1 , W 2 , W 3 , W 4 , W 5 , and W 6 are each independently a 1 to a 3 are each an integer of 1 to 4, Q 1 , Q 2 , Q 3 , Q 4 , Q 5 , and Q 6 are each independently G 1 is a group represented by —NH 2 , —CH 3 , —SO 3 H, ═O, —H, or —OH, and m is 0 or 1, and n is 0 or 1; wherein the bile acid salt is sodium glycochenodeoxycholate, sodium taurochenodeoxycholate, sodium taurocholate, sodium dehydrocholate, or sodium deoxycholate; and wherein the hydrate of the bile acid salt is sodium taurocholate hydrate or sodium cholate hydrate. 2. The composite of claim 1 , wherein the two-dimensional material is a single substance selected from the group consisting of graphene, graphene oxide, boron nitride, boron carbon nitride (BCN), tungsten oxide (WO 3 ), tungsten sulfide (WS 2 ), molybdenum sulfide (MoS 2 ), molybdenum telluride (MoTe 2 ), and manganese oxide (MnO 2 ), or a composite substance including a stack of two or more thereof. 3. The composite of claim 1 , wherein the bile acid derivative is any one of Formulas 4 to 20: (R)—N-(aminomethyl)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamide (R)-methyl-4-((3R, 5S, 7R, 8R, 9S, 10S, 12S, 13R, 14S, 17R)-3, 7, 12-trihydroxy-10, 13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate (R)-4-((3R, 5R, 8R, 9S, 10S, 13R, 14S, 17R)-3-hydroxy-10, 13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-N-(hydroxymethyl)pentanamide (R)—N-(aminomethyl)-4-((3R, 5S, 7R, 8R, 9S, 10S, 12S, 13R, 14S, 17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamide (R)-4-((3R, 5R, 7R, 8R, 9S, 10S, 13R, 14S, 17R)-7-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid 5β-cholanic acid-3α, 12α-diol 3-acetate methyl ester 5β-cholanic acid-3-one 5β-cholanic acid 3,7-dione methyl ester 5β-cholanic acid-3,7-dione Carbamic(4R)-4-((3R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic anhydride 3R,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-17-((R)-5-((2-methyl-3-oxobutan-2-yl)amino)-5-oxopentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3-sulfonic acid R)-4-oxo-7-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)octanenitrile 3-((R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)propanoic acid (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic sulfuric anhydride (R)—N-carbamoyl-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamide 4-((S)-1-((3R,5R,8R,9S,10S,12S,13S,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethyl)benzenesulfonic acid 4-((S)-1-((3R,5R,8R,9S,10S,12S,13S,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethyl)benzoic acid. 4. The composite of claim 1 , wherein the bacteriophage is a filamentous bacteriophage. 5. The composite of claim 4 , wherein the bacteriophage is at least one selected from the group consisting of T1, T2, T3, T4, T5, T6, T7, M13, MS2, fd, fl and P22. 6. The composite of claim 1 , wherein the amphiphilic substance is formed in a self assembly. 7. The composite of claim 6 , wherein hydrophilic portions of the amphiphilic substance are exposed at the exterior of the self assembly. 8. The composite of claim 6 , wherein the self assembly has a spherical, rod-shaped or fiber-shaped structure. 9. The composite of claim 6 , wherein the self assembly of the amphiphilic substance includes a core particle and one or more shells including the amphiphilic substance self-assembled on the core particle. 10. The composite of claim 9 , wherein hydrophilic portions of the amphiphilic substance are exposed at the exterior of the self assembly of the amphiphilic substance. 11. The composite of claim 9 , wherein the core particle is spherical or rod-shaped. 12. The composite of claim 9 , wherein the core
After-treatment, e.g. grinding, purification (transformation of hexagonal into cubic or wurtzitic boron nitride C04B35/5831) · CPC title
Oxidation · CPC title
obtained by TEM, STEM, STM or AFM · CPC title
Oxides; Hydroxides · CPC title
containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.